Elder Pharmaceuticals reports 10% fall in Q1 net profit

Elder Pharmaceuticals has reported results for first quarter ended June 30, 2012.

The company has reported fall of 9.94% in its net profit at Rs 18.04 crore for the quarter under review as compared to Rs 20.03 crore for the same quarter in the previous year. However, the total income from operation of the company has increased by 18% at Rs 353.98 crore for Q1FY13 as compared Rs 299.99 crore for the corresponding quarter previous year.

Elder Pharmaceuticals (EPL) has around six manufacturing units in India, all as per international standards. Post increasing its stake in Elder Biomeda AD and Neutrahealth PLC, EPL also has access to the manufacturing units of these companies in Bulgaria and Birmingham, UK respectively coupled with distribution network and brands of the same.